Viva Biotech Holdings financial statements, including revenue, expenses, profit, and loss

The total revenue of VBIZF for the last semiannual is 140.17 M USD, and it's 14.94% lower compared to the previous semiannual. The net income of H2 23 is -16.20 M USD.